Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers

This Gaucher disease review considered 3 enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health.

Scroll down to access downloads and media.

Life Saving Drugs Program – Gaucher disease – Medicines review summary for consumers

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers [PDF - 158 KB] - 3 pages

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers [Word - 109 KB] - 3 pages

About this resource

Publication date:

27 January 2023

Publication type:

Report

Audience:

General public

Language:

English

Part of a collection:

Life Saving Drugs Program resources – Gaucher disease

Tags:

Sub menu

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers

Life Saving Drugs Program – Gaucher disease – Medicines review summary for consumers

About this resource

Help us improve health.gov.au